arrivent.comHealthcareFounded: 2021Funding to Date: $260MM
ArriVent Biopharma is a drug development platform that sources oncology therapies from around the world and drives them through the approval process.
For more details on financing and valuation for ArriVent Biopharma, register or login.
View Enterprise Value for ArriVent Biopharma.
To read this article and more news on ArriVent Biopharma, register or login.